Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials
SGLT-2is and GLP-1RAs provide broadly comparable cardio-kidney benefits across sexes in patients with and without T2D. The lower representation of women in CVOTs warrants attention.
Authors
- Rohan Sanjanwala
- Ashish H. Shah (ORCID: https://orcid.org/0000-0002-9396-7178)
- Shuangbo Liu (ORCID: https://orcid.org/0000-0002-8722-0182)
- Erwin Taguiam
- Magdaline Zawadka
- Setor K. Kunutsor
- Mê‐Linh Lê
Institutions
- St. Boniface Hospital (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1111/dom.70411
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Manitoba
- Max Rady College of Medicine, University of Manitoba